News

New Sustained Release Drug Enters Trials

Aerie Pharmaceuticals, Inc. (Aerie), has begun patient dosing in their first human clinical trial of a sustained release implant in patients with wet macular degeneration or diabetic macular edema. The polymer implant provides controlled release of AR-13503, an injectable drug that inhibits blood vessel growth in the retina, while potentially reducing the treatment burden associated [Read More]

Updating The Home For Better Living With Wet AMD

Leading patient advocacy organizations collaborate on important new resource Living with wet age-related macular degeneration (AMD) poses some difficult challenges, but a new free resource called “My Home in Sight Kit” can help make adapting the living space easier. Prevent Blindness has joined with five other patient advocacy organizations* to share valuable advice based upon five [Read More]

Prevent Blindness Emphasizes Importance of Sight Care for Older Adults With Cognitive Decline

According to the Centers for Disease Control and Intervention (CDC), “Vision impairment often co-occurs with cognitive decline, which can be associated with functional limitations”. Data from Analysis of 2015–2017 Behavioral Risk Factor Surveillance System determined that, “after adjusting for age and other demographic and smoking characteristics, 18% of adults who reported vision impairment also reported [Read More]